Franz-Werner Haas, CureVac CEO (Christoph Schmidt/picture-alliance/dpa/AP Images)

February 5, 2021 07:16 AM ESTUpdated 10:11 AM

Covid-19 roundup: UK and CureVac join forces to fight emerging variants; Sanofi and GlaxoSmithKline post snapshot of PhI/II vaccine data

The UK’s Vaccines Taskforce will work with CureVac to track new variants and generate vaccine candidates against them, according to a

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: UK and Cure­Vac join forces to fight emerg­ing vari­ants; Sanofi and Glax­o­SmithK­line post snap­shot of PhI/II vac­cine da­ta